Bishara Touma, MD
Otology & Neurotology · Huntington, WVNPI 1851393474
Payments from drug & device makers
Across 127 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$458
- Novo Nordisk$382
- Amarin Pharma, Inc.$122
- Bayer$121
- Merck$88
- AstraZeneca$84
- plus $752 from 23 others
What the payments were for
- Food & beverage$2,008100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 31 | $458 |
| Novo Nordisk | 25 | $382 |
| Amarin Pharma, Inc. | 9 | $122 |
| Bayer | 8 | $121 |
| Merck | 5 | $88 |
| AstraZeneca(2 entities) | 4 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $78 |
| Lilly USA, LLC | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Sunovion Pharmaceuticals Inc. | 4 | $67 |
| GSK | 5 | $66 |
| Paratek Pharmaceuticals, Inc. | 3 | $53 |
| Cvrx, Inc. | 2 | $37 |
| Abbott | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Aurinia Pharma U.S., Inc. | 1 | $28 |
| Johnson & Johnson | 2 | $26 |
| Philips North America LLC | 1 | $23 |
| Biogen | 1 | $22 |
| Insulet Corporation | 1 | $21 |
| Boehringer Ingelheim | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Smith+Nephew | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
How this compares
Too few otology & neurotology providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 81 | $9,079 |
| Ofloxacin | 123 | $4,672 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 24 | $1,350 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 74 | $704 |
| Fluticasone Propionate | 43 | $694 |
| Clonazepam | 222 | $632 |
| Ipratropium Bromide | 14 | $584 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $514 |
| Diazepam | 152 | $410 |
| Azelastine Hcl | 12 | $346 |
| Meclizine Hcl | 48 | $312 |
| Methylprednisolone | 34 | $239 |
| Ondansetron OdtOndansetron | 15 | $158 |
| Mupirocin | 12 | $79 |
| Ondansetron Hcl | 18 | $75 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Huntington
- Joseph ToumaHuntington$1K
- Stephen WetmoreMorgantown$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.